These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20203158)

  • 1. siRNA-based therapy ameliorates glomerulonephritis.
    Shimizu H; Hori Y; Kaname S; Yamada K; Nishiyama N; Matsumoto S; Miyata K; Oba M; Yamada A; Kataoka K; Fujita T
    J Am Soc Nephrol; 2010 Apr; 21(4):622-33. PubMed ID: 20203158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically modified siRNA prolonged RNA interference in renal disease.
    Takabatake Y; Isaka Y; Mizui M; Kawachi H; Takahara S; Imai E
    Biochem Biophys Res Commun; 2007 Nov; 363(2):432-7. PubMed ID: 17880921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring RNA interference as a therapeutic strategy for renal disease.
    Takabatake Y; Isaka Y; Mizui M; Kawachi H; Shimizu F; Ito T; Hori M; Imai E
    Gene Ther; 2005 Jun; 12(12):965-73. PubMed ID: 15729369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo transfer of small interfering RNA or small hairpin RNA targeting glomeruli.
    Takabatake Y; Isaka Y; Imai E
    Methods Mol Biol; 2009; 466():251-63. PubMed ID: 19148605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New short interfering RNA-based therapies for glomerulonephritis.
    Shimizu H; Fujita T
    Nat Rev Nephrol; 2011 May; 7(7):407-15. PubMed ID: 21610682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
    Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
    Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.
    Tomita N; Morishita R; Yamamoto K; Higaki J; Dzau VJ; Ogihara T; Kaneda Y
    J Gene Med; 2002; 4(5):527-35. PubMed ID: 12221646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation.
    Jantsch J; Turza N; Volke M; Eckardt KU; Hensel M; Steinkasserer A; Willam C; Prechtel AT
    J Immunol Methods; 2008 Aug; 337(1):71-7. PubMed ID: 18514219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
    J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.